ISSN 1016-5169 | E-ISSN 1308-4488
pdf
Relation between mean platelet volume and subclinical atherosclerosis in patients with metabolic syndrome [Turk Kardiyol Dern Ars]
Turk Kardiyol Dern Ars. 2014; 42(1): 22-28 | DOI: 10.5543/tkda.2014/50708

Relation between mean platelet volume and subclinical atherosclerosis in patients with metabolic syndrome

Ali Rıza Gülcan1, Mustafa Serkan Karakaş2, Barış Akdemir3, Mustafa Uçar4, Refik Emre Altekin4, Hüseyin Yılmaz4
1Sanlıurfa Research and Education Hospital, Department of Cardiology, Sanlıurfa, Turkey
2Nigde State Hospital, Department of Cardiology, Nigde, Turkey
3Burdur State Hospital, Department of Cardiology, Burdur, Turkey
4Akdeniz University Medical Faculty, Department of Cardiology, Antalya, Turkey


OBJECTIVES
Metabolic syndrome (MetS) is associated with increased cardiovascular morbidity and mortality. There is evidence of platelet activation in MetS. Mean platelet volume (MPV), a determinant of platelet activation, is a newly emerging risk factor for atherothrombosis. Therefore, we investigated the possible association between subclinical atherosclerosis, as evaluated by carotid intima-media thickness (CIMT) measurement and MPV, in MetS patients.

STUDY DESIGN
Seventy-four patients with MetS were enrolled in the study. Patients were divided into two groups according to CIMT measurement: 35 patients with CIMT ≥1.0 mm were in Group 1 and 39 patients with CIMT <1.0 mm were in Group 2. MPV was measured using an automated blood cell counter.

RESULTS
The MPV level was significantly higher in patients with CIMT ≥1.0 mm than in patients with CIMT <1.0 mm (8.2±0.7 vs. 7.8±0.6 fl; p=0.01). In our study, we observed that platelet count was lower in KIMK ≥1.0 mm group and this finding was also found to be statistically significant.

CONCLUSION
The risk of atherosclerosis could be shown by following the MPV values in MetS patients. Therefore, our results suggest that MPV is an important marker for early detection of atherosclerotic risk in patients with MetS.

Keywords: Atherosclerosis, metabolic syndrome X; blood platelets/ pathology; platelet activation; platelet count.

Corresponding Author: Ali Rıza Gülcan, Türkiye
Manuscript Language: Turkish
×
APA
NLM
AMA
MLA
Chicago
Copied!
CITE


Journal Metrics

Journal Citation Indicator: 0.18
CiteScore: 1.1
Source Normalized Impact
per Paper:
0.22
SCImago Journal Rank: 0.348

Quick Search



Copyright © 2024 Archives of the Turkish Society of Cardiology



Kare Publishing is a subsidiary of Kare Media.